| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |